Division of Movement Disorders

Medicine & Life Sciences

1. Parkinson Disease 100%
2. Huntington Disease 30%
3. Dystonia 28%
4. Positron-Emission Tomography 25%
5. Parkinsonian Disorders 24%
6. Brain 24%
7. Synucleins 22%
8. Deep Brain Stimulation 19%
9. Manganese 18%
10. Primates 18%
11. Levodopa 18%
12. Dystonic Disorders 18%
13. Corpus Striatum 17%
14. Dopamine 16%
15. Torticollis 15%
16. Subthalamic Nucleus 15%
17. Tremor 14%
18. Vesicular Acetylcholine Transport Proteins 11%
19. Mental Status and Dementia Tests 10%
20. Genes 10%
21. Gait 10%
22. Cerebrovascular Circulation 10%
23. Mutation 10%
24. Macaca 10%
25. Putamen 10%
26. Regional Blood Flow 9%
27. Neurons 9%
28. Alzheimer Disease 8%
29. Type A Botulinum Toxins 8%
30. N-methylbenperidol 8%
31. Haplorhini 8%
32. Papio 8%
33. Basal Ganglia 8%
34. Movement Disorders 8%
35. Dopamine D2 Receptors 7%
36. Dementia 7%
37. Welding 7%
38. Cerebellum 7%
39. Amyloid 7%
40. Learning 7%
41. Neurodegenerative Diseases 7%
42. Blepharospasm 7%
43. Dopamine D3 Receptors 7%
44. Magnetic Resonance Imaging 7%
45. Substantia Nigra 6%
46. Neuroimaging 6%
47. Essential Tremor 6%
48. Lewy Bodies 6%
49. Saccades 6%
50. Injections 6%
51. Age of Onset 6%
52. Occupational Groups 6%
53. Therapeutics 6%
54. Medicare 6%
55. In Vitro Techniques 5%
56. Ligands 5%
57. Placebos 5%
58. Dyskinesias 5%
59. Confidence Intervals 5%
60. Phenotype 5%
61. 4-phenyl-1,2,3,6-tetrahydropyridine 5%
62. Quality of Life 5%
63. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine 5%
64. Head 5%
65. Hand 5%
66. Motor Cortex 5%